Comprehensive Childcare
According to World Health Organization (WHO), diarrheal disease is the second leading cause of death in children under five years. Dysbiosis characterized by pathogens domination is widely identified in diarrheal diseases. Research in gut microbiota is receiving large amount of attention due to its involvement in diarrhoea…
Global prevalence of infantile colic pain is estimated to be around 20% but most of the research has been done in Western population. Alteration in gut microorganism or more correctly decrease in commensal bacteria like Lactobacillus and Bifidobacterium in gut of the babies is a reason for colic…
According to World Health Organisation (WHO), diarrhoeal disease is the second leading cause of death in children under five years. Dysbiosis characterized by pathogens domination is widely identified in diarrheal diseases. Research in gut microbiota is receiving large amount of attention due to its involvement in diarrhoea.
Current management includes treatment with antibiotics, ORS for rehydration and zinc. Antibiotics not only kill infection-causing bacteria but also disturb the balance of the gut microbiota, potentially allowing certain pathogenic bacteria to become overactive. Hence supplementation of gut beneficial bacteria may be an effective strategy for the management of diarrhoea.
BLM LrGG contains Lactobacillus rhamnosus GG which is the world’s most researched and documented probiotic; that is globally recommended by several eminent authorities. It has clinically proven efficacy and safety in various gastrointestinal conditions, through multiple clinical trials. L. rhamnosus GG is safe to be used across all age groups – ranging from kids to the elderly. It could decrease the frequency, duration of diarrhoea & vomiting and the recovery is 50% faster than the standard treatment of care.
Sachet
One sachet a day
Drops
7 drops a day
Global prevalence of infantile colic pain is estimated to be around 20% but most of the research has been done in western population. Alteration in gut microorganism or more correctly decrease in commensal bacteria like lactobacillus and bifidobacterium in gut of babies is a reason for colic pain. Relative abundance of opportunistic and commensal enterobacterial species seem to increase in infant colic in comparison to healthy infants. These bacteria are known to produce gas as a result of their metabolism, which could facilitate bloating and digestive discomfort. Hence, proliferating the infants gut with healthy bacteria seems to be a rational solution.
BLM ColiBiome is a combination of 2 patented probiotic strains Pediococcus pentosaceus and Bifidobacterium longum. Infants who received BLM ColiBiome demonstrated a gradual effect from the first day, both in reducing daily crying time & in reducing the number of episodes each day. Clinical trials have confirmed BLM ColiBiome caused 33% reduction in daily crying time and 61% reduction in crying episodes. It also reduces the relative abundance of pathogenic bacteria associated with infant colic pain.
